国产乱伦 celebrates and recognises our editors and teams for their achievements in editorial board development, journal growth, increasing diversity, and more. In this blog series, based on inspirational contributions from the 2023 Celebrating Editorial Impact event, editors-in-chief from across 国产乱伦 share exciting and innovative initiatives they are pursuing, the journey to implementing them, and the impact these have had on their journals and communities.
In today鈥檚 post, Prof. Sobha Sivaprasad, Editor-in-Chief of Eye, shares some strategies that brought the journal substantial growth over the past few years, and the various measurements to evaluate this.
Growing the visibility and impact of a scientific journal enhances the dissemination of knowledge within the scientific community. Attracting a broader readership can translate to more citations, and subsequently a higher impact factor. In turn, the journal attracts more and higher quality submissions, further influencing reputation and influence.
Ultimately, the growth of a scientific journal contributes to its sustainability, and thus to scientific and societal advancements through its publications and their impact.
In 2018 I took on the role of editor-in-chief of , the official journal of the Royal College of Ophthalmologists in the UK, supported by managing editor Steve Beet. Since then, I鈥檝e seen the journal grow exponentially.
In the following, I will discuss journal growth measurements as well as some of the strategies that contributed to Eye鈥檚 growth. But first I would like to acknowledge that the journal鈥檚 success is owed to the people who generously contribute their time and expertise: our editorial board members, reviewers, and authors.
Impact Factor and citation count are the usual suspects when thinking about measuring a scientific journal鈥檚 growth. But these are not the only measurements to focus on.
Indeed, Eye has enjoyed a substantial jump in its Impact Factor from 2.455 in 2019 to 2.8 in 2023. It has consistently ranked highly among Ophthalmology journals, 14th out of 62 journals in 2022 and 23rd out of 95 journals in 2023.
In addition to these, Eye has also shown substantial growth in other measures of journal performance:
Looking at the geographic spread of the journal鈥檚 web traffic by region in 2022-2023, usage is evidently globally spread. While most requests do come from the United States and the United Kingdom, as well as other European and Asian locations, I am glad to say that requests from other parts of the world are on the rise.
In usage metrics, Eye has seen a massive growth from 1,246,324 downloads in 2019 to 3,222,387 downloads in 2023.
The number of publications has risen from 341 in 2018 to 508 in 2022, and submissions have grown from 1,200 in 2018 to over 1,800 in 2022.
Looking back, I can identify several key strategies that contributed to the growth of Eye: focusing on diversity; publishing special issues with guest editors; organising collections; and inviting reviews.
1. Diversity, equity, and inclusion (DEI). Championing DEI is crucial to making journal publishing inclusive and representative, and it supports growth by making the journal more visible and accessible to larger audiences.
2. Special issues and collections. Gathering research outputs around specific topics is an opportunity to draw attention to a journal and expand its visibility.
3. Invited reviews. Inviting well-known experts and authors with specific specialisations to contribute to the journal is significant in broadening readership and showcasing emerging or controversial research trends.
Eye has seen growth in various measurements, such as web traffic and downloads mentioned earlier, and also in various key statistics such as its Immediacy Index (which rose from 0.6 in 2022 to 0.8 in 2023) and its Article Influence Score (growing from 1.050 in 2022 to 1.088 in 2023). In 2023, Eye鈥檚 most recent 5-year Impact Factor was recorded as 3.5, with a 1.02 Journal Citation Indicator.
But most notably, Eye has maintained its growth momentum also as the wider ophthalmology field saw a reduction in outputs in 2023. I am looking forward to working further with our authors and reviewers to continue growing Eye and its community and maintaining its relevance to science and practice.